← Evidence map

ArticleClinical & experimental metastasis2016

Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.

Juan Garona et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27146156